Common in hospitalised patients with sepsis, trauma, surgery, or critical illness.
Hormonal profile:
o ↑ Cortisol – due to stress-induced activation of the HPA axis.
o ↓ T3 (low total and free T3) with normal or low-normal T4 and TSH → "sick euthyroid" pattern.
o ↑ Growth hormone, but with hepatic GH resistance, leading to low IGF-1.
o ↑ Catecholamines and glucagon.
o Stress hyperglycaemia – due to ↑ cortisol, catecholamines, insulin resistance.
Thyroid hormone replacement is not indicated unless true hypothyroidism is suspected.
Hormonal alterations reflect and contribute to insulin resistance and metabolic syndrome.
Endocrine profile:
o ↑ Leptin – due to increased adipose mass, but with leptin resistance.
o ↓ GH – obesity suppresses GH secretion; IGF-1 may be low/normal.
o ↑ Insulin – compensatory hyperinsulinaemia due to peripheral resistance.
o Altered sex hormones – ↑ oestrogens (aromatisation), ↓ SHBG, ↑ androgens in women.
↑ risk of developing T2DM, PCOS, NAFLD.
Static hormone tests
Single blood measurements taken at rest. Useful for hormones with stable levels.
Examples:
o TSH, free T4, prolactin, sex hormones (e.g. testosterone, oestradiol), calcium, PTH.
o Must interpret with circadian and menstrual variations in mind.
Dynamic hormone tests
Assess endocrine gland responsiveness by stimulation or suppression.
Indicated when static levels are equivocal or physiology is complex.
Common examples:
o Dexamethasone suppression test (Cushing’s syndrome):
– Low-dose: tests cortisol suppression.
– High-dose: distinguishes pituitary vs ectopic ACTH.
o Short Synacthen test (primary adrenal insufficiency):
– Synthetic ACTH given → assess cortisol response.
– Impaired in Addison’s disease.
o Insulin tolerance test (ITT) – gold standard for GH and ACTH reserve.
o OGTT with GH measurement – for acromegaly (failure to suppress GH).
o Water deprivation test – for diagnosis of diabetes insipidus.
Always interpret tests in the context of timing, clinical state, and medication history (e.g. oestrogen increases TBG; steroids suppress HPA axis).
————————————————————————————————————————————————————————————————————————————————————————————————————————-
Author & Educational Disclaimer
Author:
Dr Phillip Cockrell BM FRCP DipClinEd
Dr Phillip Cockrell is a UK Consultant Physician in Internal Medicine, currently working at Queen Alexandra Hospital, Portsmouth University Hospitals NHS Trust. He has previously worked as a registrar across Intensive Care Medicine, Gastroenterology, Cardiology, Stroke Medicine, Acute Medicine, and Respiratory Medicine.
He has held senior leadership roles including Associate Clinical Director of the Acute Medical Unit, Clinical Director of Internal Medicine, and Chief of Medicine. Dr Cockrell has over 15 years’ experience in postgraduate medical education, having lectured extensively across the MRCP syllabus and contributed to MRCP revision teaching and course development.
Dr Cockrell holds a Bachelor of Medicine (BM), Fellowship of the Royal College of Physicians (FRCP), and a Diploma in Clinical Education (DipClinEd). His teaching approach is based on structured consolidation of complex medical topics to support efficient and effective revision for postgraduate examinations.
Purpose of this content:
The material on this page is intended solely for educational purposes to support revision for the MRCP (UK) Part 1 examination. It reflects examination-relevant principles of internal medicine and is designed to aid learning and pattern recognition.
Medical disclaimer:
This content is designed for postgraduate medical examination revision and does not constitute medical advice, diagnosis, or treatment guidance and must not be used as a substitute for professional clinical judgement, local guidelines, or specialist consultation. Clinical decisions should always be made in the context of individual patient circumstances and current national guidance.